GDPD5 and breast carcinoma: HR-MAS MRS and gene expression analyses demonstrated that the amount of Cho, PCho and GPC correlated with the expression of several genes, including CHKA and GDPD5, in the Cho metabolism pathway in tissue samples from patient-derived breast cancer xenografts representing luminal-like, basal-like and HER2 enriched breast cancer.